16.47
price up icon8.43%   1.28
after-market Dopo l'orario di chiusura: 16.47
loading
Precedente Chiudi:
$15.19
Aprire:
$15.23
Volume 24 ore:
119.79K
Relative Volume:
0.76
Capitalizzazione di mercato:
$1.01B
Reddito:
-
Utile/perdita netta:
$-42.21M
Rapporto P/E:
-13.50
EPS:
-1.22
Flusso di cassa netto:
$-33.16M
1 W Prestazione:
-3.35%
1M Prestazione:
+3.07%
6M Prestazione:
+110.61%
1 anno Prestazione:
+234.76%
Intervallo 1D:
Value
$15.13
$16.60
Intervallo di 1 settimana:
Value
$14.06
$18.09
Portata 52W:
Value
$4.571
$22.69

Pulse Biosciences Inc Stock (PLSE) Company Profile

Name
Nome
Pulse Biosciences Inc
Name
Telefono
510-906-4600
Name
Indirizzo
3957 POINT EDEN WAY, HAYWARD, CA
Name
Dipendente
56
Name
Cinguettio
@PulseBioNPS
Name
Prossima data di guadagno
2024-10-30
Name
Ultimi documenti SEC
Name
PLSE's Discussions on Twitter

Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2021-07-27 Iniziato Stephens Overweight
2021-03-11 Iniziato Maxim Group Buy
2021-01-26 Reiterato H.C. Wainwright Buy
2020-05-12 Aggiornamento H.C. Wainwright Neutral → Buy
2020-02-14 Downgrade H.C. Wainwright Buy → Neutral
2019-02-25 Iniziato H.C. Wainwright Buy
Mostra tutto

Pulse Biosciences Inc Borsa (PLSE) Ultime notizie

pulisher
04:27 AM

Pulse Biosciences (NASDAQ:PLSE) Trading 7.6% HigherStill a Buy? - MarketBeat

04:27 AM
pulisher
Nov 04, 2024

Critical Analysis: Pulse Biosciences (NASDAQ:PLSE) and Spectral AI (NASDAQ:MDAI) - Defense World

Nov 04, 2024
pulisher
Nov 01, 2024

Pulse Biosciences, Inc. (NASDAQ:PLSE) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 01, 2024
pulisher
Oct 31, 2024

Pulse Biosciences Reports Positive Data From Benign Thyroid Study - MarketWatch

Oct 31, 2024
pulisher
Oct 31, 2024

Pulse Biosciences Announces Positive Clinical Data Presented at the American Thyroid Association - StockTitan

Oct 31, 2024
pulisher
Oct 31, 2024

Pulse Biosciences Appoints David Kenigsberg, M.D. As Chief Medical Officer Of Electrophysiology - citybiz

Oct 31, 2024
pulisher
Oct 31, 2024

Pulse Biosciences (NASDAQ:PLSE) Announces Earnings Results - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

Pulse Biosciences Inc Reports Q3 2024 GAAP Net Loss of $12.7 Mil - GuruFocus.com

Oct 31, 2024
pulisher
Oct 31, 2024

Pulse Biosciences (NASDAQ:PLSE) Shares Pass Below 50-Day Moving AverageWhat's Next? - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

Pulse Biosciences Inc (PLSE) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance

Oct 31, 2024
pulisher
Oct 31, 2024

Pulse Biosciences Reports Q3 2024 Financials and Developments - TipRanks

Oct 31, 2024
pulisher
Oct 30, 2024

Pulse Biosciences appoints new electrophysiology CMO - Investing.com

Oct 30, 2024
pulisher
Oct 30, 2024

Pulse Biosciences Reports Business Updates and Third Quarter 2024 Financial Results - The Bakersfield Californian

Oct 30, 2024
pulisher
Oct 30, 2024

Pulse Biosciences Announces Appointment of David Kenigsberg, M.D. as Chief Medical Officer of Electrophysiology - StockTitan

Oct 30, 2024
pulisher
Oct 29, 2024

(PLSE) Trading Report - Stock Traders Daily

Oct 29, 2024
pulisher
Oct 23, 2024

Pulse Biosciences (NASDAQ:PLSE) Stock Price Down 7.4%What's Next? - MarketBeat

Oct 23, 2024
pulisher
Oct 23, 2024

Pulse Biosciences (PLSE) Scheduled to Post Earnings on Wednesday - MarketBeat

Oct 23, 2024
pulisher
Oct 21, 2024

Pulse Biosciences Schedules Third Quarter 2024 Financial Results Conference Call for October 30, 2024 - StockTitan

Oct 21, 2024
pulisher
Oct 19, 2024

Pulse Biosciences (NASDAQ:PLSE) Stock Passes Below 50 Day Moving AverageWhat's Next? - MarketBeat

Oct 19, 2024
pulisher
Oct 14, 2024

(PLSE) On The My Stocks Page - Stock Traders Daily

Oct 14, 2024
pulisher
Oct 11, 2024

Renaissance Technologies LLC Lowers Stock Holdings in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World

Oct 11, 2024
pulisher
Oct 10, 2024

Pulse Biosciences (NASDAQ:PLSE) Shares Cross Below 50 Day Moving AverageShould You Sell? - MarketBeat

Oct 10, 2024
pulisher
Oct 05, 2024

PLSE MONDAY DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Pulse Biosciences, Inc. Investors With Losses Over $100K to Secure Counsel Before Important April 18 Deadline in Securities Class ActionPLSE - AsiaOne

Oct 05, 2024
pulisher
Oct 04, 2024

Long Term Trading Analysis for (PLSE) - Stock Traders Daily

Oct 04, 2024
pulisher
Oct 02, 2024

Pulse Biosciences (NASDAQ:PLSE) Shares Gap Down to $17.54 - MarketBeat

Oct 02, 2024
pulisher
Oct 01, 2024

Pulse Biosciences (NASDAQ:PLSE) Shares Down 5% - MarketBeat

Oct 01, 2024
pulisher
Oct 01, 2024

Pulse Biosciences (NASDAQ:PLSE) Stock Price Down 5% - Defense World

Oct 01, 2024
pulisher
Sep 24, 2024

Bank of New York Mellon Corp Buys 9,639 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World

Sep 24, 2024
pulisher
Sep 23, 2024

Pulse Biosciences (NASDAQ:PLSE) Shares Down 5.4% - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Pulse Biosciences Inc [PLSE] Investment Appeal on the Rise - Knox Daily

Sep 23, 2024
pulisher
Sep 23, 2024

How To Trade (PLSE) - Stock Traders Daily

Sep 23, 2024
pulisher
Sep 23, 2024

Metric Deep Dive: Understanding Pulse Biosciences Inc (PLSE) Through its Ratios - The Dwinnex

Sep 23, 2024
pulisher
Sep 22, 2024

Inspire Investing LLC Sells 8,725 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World

Sep 22, 2024
pulisher
Sep 21, 2024

Pulse Biosciences (NASDAQ:PLSE) Upgraded by StockNews.com to "Sell" - MarketBeat

Sep 21, 2024
pulisher
Sep 21, 2024

Pulse Biosciences (NASDAQ:PLSE) Upgraded to “Sell” at StockNews.com - Defense World

Sep 21, 2024
pulisher
Sep 18, 2024

Pulse Biosciences (NASDAQ:PLSE) Shares Gap Up to $18.51 - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Quest Partners LLC Purchases New Shares in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World

Sep 18, 2024
pulisher
Sep 15, 2024

Pulse Biosciences (NASDAQ:PLSE) Shares Down 2.7% - Defense World

Sep 15, 2024
pulisher
Sep 11, 2024

Keeping an Eye on Pulse Biosciences Inc (PLSE) After Insider Trading Activity - Knox Daily

Sep 11, 2024
pulisher
Sep 10, 2024

Pulse Biosciences (NASDAQ:PLSE) Trading Up 7% - MarketBeat

Sep 10, 2024
pulisher
Sep 09, 2024

Paul LaViolette Joins Pulse Bioscience's Board Of Directors - MPO-mag

Sep 09, 2024
pulisher
Sep 03, 2024

Pulse Biosciences (NASDAQ:PLSE) Trading Down 9.6% - MarketBeat

Sep 03, 2024
pulisher
Sep 02, 2024

Pulse Biosciences Inc (PLSE) may enjoy gains as insiders got busy in the recent days - Knox Daily

Sep 02, 2024
pulisher
Sep 02, 2024

Ratios in Focus: Analyzing Pulse Biosciences Inc (PLSE)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Sep 02, 2024
pulisher
Aug 28, 2024

Pulse Biosciences Inc [PLSE] Investment Guide: What You Need to Know - Knox Daily

Aug 28, 2024
pulisher
Aug 28, 2024

(PLSE) Technical Data - Stock Traders Daily

Aug 28, 2024
pulisher
Aug 28, 2024

Seborrheic Keratosis Treatment Market Report 2024-2030, Featuring Comprehensive Profiles of Aclaris Therapeutics, Alma Lasers, BIOLASE, BioLineRx, DermBiont, Novartis and Pulse Biosciences - GlobeNewswire

Aug 28, 2024
pulisher
Aug 28, 2024

Seborrheic Keratosis Treatment Market Report 2024-2030, Featuring Comprehensive Profiles of Aclaris - Daily Guardian Canada

Aug 28, 2024
pulisher
Aug 28, 2024

Pulse Biosciences (NASDAQ:PLSE) Trading Down 8.1% - MarketBeat

Aug 28, 2024
pulisher
Aug 24, 2024

Pulse Biosciences (NASDAQ:PLSE) Shares Gap Down to $19.96 - Defense World

Aug 24, 2024
pulisher
Aug 23, 2024

Pulse Biosciences (NASDAQ:PLSE) Trading Up 3.9% - MarketBeat

Aug 23, 2024

Pulse Biosciences Inc Azioni (PLSE) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Pulse Biosciences Inc Azioni (PLSE) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
DUGGAN ROBERT W
Director
Dec 12 '23
Buy
9.15
17,999
164,691
36,984,179
DUGGAN ROBERT W
Director
Dec 11 '23
Buy
9.36
90,118
843,504
36,966,180
DUGGAN ROBERT W
Director
Dec 08 '23
Buy
9.54
116,656
1,112,898
36,876,062
DUGGAN ROBERT W
Director
Dec 07 '23
Buy
9.19
74,852
687,890
36,759,406
DUGGAN ROBERT W
Director
Dec 06 '23
Option Exercise
5.95
9,933
59,101
36,601,741
DUGGAN ROBERT W
Director
Dec 06 '23
Buy
9.06
82,813
750,286
36,684,554
DUGGAN ROBERT W
Director
Dec 05 '23
Buy
9.34
66,021
616,636
351,565
DUGGAN ROBERT W
Director
Dec 04 '23
Option Exercise
10.66
40,347
430,099
36,591,808
DUGGAN ROBERT W
Director
Dec 04 '23
Buy
10.38
27,000
280,260
285,544
DUGGAN ROBERT W
Director
Dec 01 '23
Buy
9.07
45,600
413,592
258,544
$22.77
price up icon 0.98%
$212.15
price up icon 0.65%
medical_instruments_supplies BAX
$36.10
price up icon 0.84%
$78.80
price down icon 5.88%
medical_instruments_supplies COO
$105.21
price up icon 0.33%
medical_instruments_supplies WST
$323.47
price up icon 2.76%
Capitalizzazione:     |  Volume (24 ore):